Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Assets (2023 - 2025)

Historic Assets for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $729.9 million.

  • CG Oncology's Assets rose 3211.79% to $729.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $729.9 million, marking a year-over-year increase of 3211.79%. This contributed to the annual value of $754.8 million for FY2024, which is 27872.21% up from last year.
  • Latest data reveals that CG Oncology reported Assets of $729.9 million as of Q3 2025, which was up 3211.79% from $701.4 million recorded in Q2 2025.
  • CG Oncology's 5-year Assets high stood at $754.8 million for Q4 2024, and its period low was $199.3 million during Q4 2023.
  • Moreover, its 3-year median value for Assets was $640.3 million (2024), whereas its average is $601.2 million.
  • Per our database at Business Quant, CG Oncology's Assets skyrocketed by 27872.21% in 2024 and then skyrocketed by 2429.7% in 2025.
  • CG Oncology's Assets (Quarter) stood at $199.3 million in 2023, then skyrocketed by 278.72% to $754.8 million in 2024, then decreased by 3.3% to $729.9 million in 2025.
  • Its Assets stands at $729.9 million for Q3 2025, versus $701.4 million for Q2 2025 and $728.2 million for Q1 2025.